Navigation Links
Fireflies' glow helps UT Southwestern researchers track cancer drug's effectiveness
Date:5/28/2008

DALLAS May 29, 2008 The gene that allows fireflies to flash is helping researchers track the effectiveness of anti-cancer drugs over time.

UT Southwestern Medical Center researchers are among the first to show that a technique called bioluminescence imaging (BLI) can be used to determine the effectiveness of cancer drugs that choke off a tumors blood supply.

The technique requires a substrate called luciferin to be added to the bloodstream, which carries it to cells throughout the body. When luciferin reaches cells that have been altered to carry the firefly gene, those cells emit light.

Some cancer drugs, however, work by cutting off the blood supply to tumor cells. Given that luciferin is delivered via the vasculature, the researchers set out to determine the kinetics of luciferin delivery and whether BLI techniques could be used to gauge the effectiveness of drugs that destroy blood vessels that feed tumors.

They tested their theory in mice bearing human breast-cancer tumors. Before being introduced to the animals, the tumor cells had been transfected with the firefly gene, which becomes part of the cells as they divide and grow just like genetically modified, herbicide-resistant food crops.

For the study, researchers used BLI to monitor light emissions from tumors following administration of the luciferin. While the mice didnt visibly glow, the researchers used special light-detecting equipment to observe strong correlations between the amount of light emitted and the size of the tumor as it grew. Detected light emission, however, was severely reduced after the vascular-disrupting drug was administered.

What weve done is offer proof-of-concept that BLI may be an effective and cheaper method to assess drug development and effectiveness, said Dr. Ralph Mason, professor of radiology, director of the UT Southwestern Cancer Imaging Center and senior author of the study. The technique is not intended to be used for imaging tumors or diagnosing cancer in humans, but it potentially allows us to do much more efficient pre-clinical experiments.

Dr. Mason stressed that light-emission kinetics depend heavily on tumor location.

The findings are available online and in a future issue of the Journal of the Federation of American Societies for Experimental Biology.

Although magnetic resonance imaging (MRI) remains the gold standard of medical imaging, BLI has its advantages. The noninvasive procedure allows detection of cell viability not accessible by MRI and is less costly, according to researchers at UT Southwestern.

Ultimately, the MRI is much more sophisticated and can do more, but BLI is very straight-forward, Dr. Mason said. Its perfect for evaluating new classes of drugs designed to cause acute vascular changes in tumors because the tests are inexpensive and easy to do.

Dr. Mason said its critically important to develop new chemotherapeutic drugs because existing therapies, when used on their own, are far from ideal. Were lacking the optimal drugs as demonstrated by the people who are not cured by chemotherapy, he said.

He said many existing drugs kill 99 percent of a tumor but allow a few cells to survive, giving the tumor an opportunity to grow back.

Therefore, you need to do a lot of tests to optimize dosing, optimize repeat delivery and probably optimize the co-administration of other, more traditional drugs or therapies, he said. BLI provides an opportunity to do those tests cheaply and efficiently.

Dr. Mason said a handful of faculty members spent several months and about $50,000 to build the BLI instrument they used to collect this data. The team needed the charge-coupled device to detect the light emitted by the cancer cells because the light is too weak for human eyes to see.

Dr. Mason said the device is essentially an astronomy kit.

When youre looking at the stars, youre trying to assess very weak light signals, he said. Were using the same type of instrument to access very weak light coming out of an animal. The difference is that here, we have a very sensitive camera instead of a telescope.


'/>"/>

Contact: Kristen Holland Shear
kristen.hollandshear@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

Related medicine news :

1. Monitoring blood flow helps improve prostate biopsies, Jefferson researchers report
2. U.S. Web Site Helps Consumers Compare Hospitals
3. New Anticoagulation Management Software Helps Clinics Enhance Efficiency and Improve Patient Safety
4. Nutritionist to the Stars Helps to Launch European Liquid Appetite Controller
5. Protein Helps ID Thyroid Cancer Nodules
6. Blood Test Helps Docs Assess Breast Cancer Treatment
7. New Supplement Helps Americans Eat Less Every Day
8. New Presidential $1 Coin Helps Highlight National Stroke Awareness Month This May
9. Salient Corporations Performance Management Solution Helps NY State Counties Identify Medicaid Fraud, Waste, and Abuse
10. Web Site Helps Patients Prepare for Hospital Stay
11. Computer Program Helps Drug Abusers Stay Clean
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fireflies' glow helps UT Southwestern researchers track cancer drug's effectiveness
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) sponsors ... on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, ... to helping service members that have been wounded in battle and their families. Venture ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
Breaking Medicine Technology: